Fertility Market Size, Growth, Demands Outlook and Forecasts to 2027

According to the research report, the global fertility market size is expected to touch USD 45.40 Billion by 2027, from USD 26.88 Billion in 2020, growing with a significant CAGR of 4.7% from 2021 to 2027.

Fertality Market Size 2020 to 2027

The fertility market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global fertility market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global fertility market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global fertility market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1202

Report Scope of the Fertility Market

Report Highlights	Details
Market Size	USD 45.40 Billion by 2027
Growth Rate	CAGR of 4.7% From 2021 to 2027
Base Year	2020
Historic Data	2017 to 2020
Forecast Period	2021 to 2027
Segments Covered	Offering, End user
Regional Scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned	Boston IVF Fertility Clinic, INVO Bioscience, San Diego Fertility Center, Celmatix, FUJIFILM IRVINE SCIENTIFIC, Carolinas Fertility Institute, Progyny Inc., Cook Medical, LifeGlobal Group (Cooper Surgical)

This study covers a detailed segmentation of the global fertility market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global fertility market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

Boston IVF Fertility Clinic
INVO Bioscience
San Diego Fertility Center
Celmatix
FUJIFILM IRVINE SCIENTIFIC
Carolinas Fertility Institute
Progyny Inc.
Cook Medical
LifeGlobal Group (Cooper Surgical)

Market Segmentation

By Offering

Assisted Reproductive Technology
- - IVF
  - Artificial Insemination
  - Surrogacy
  - Others
Fertility Drugs
- - Gonadotropin
  - Anti-estrogen
  - Others
Others

By End user

Fertility Clinics
Hospitals
Clinical Research Institutes

By Geography

North America
- - U.S.
  - Canada
Europe
- - Germany
  - France
  - United Kingdom
  - Rest of Europe
Asia Pacific
- - China
  - Japan
  - India
  - Southeast Asia
  - Rest of Asia Pacific
Latin America
- - Brazil
  - Rest of Latin America
Middle East & Africa (MEA)
- - GCC
  - North Africa
  - South Africa
  - Rest of Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global fertility market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global fertility market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Fertility Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Fertility Market

5.1. Covid-19: fertility Industry Impact
5.2. fertility Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and fertility Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for fertility Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Fertility Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Declining fertility rates across the globe
6.1.1.2. Rising number of fertility clinics worldwide, coupled with technological advancements
6.1.2. Market Restraints
6.1.2.1. High procedural cost of assisted reproductive techniques in developed markets
6.1.3. Market Opportunities
6.1.3.1. Use of fertility treatment options by single parents and same-sex couples

Chapter 7. Global Fertility Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. fertility Market Revenue by Market Players (2017 - 2020)
7.1.1.2. fertility Market Revenue Market Share by Market Players (2017 - 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Fertility Market, By Offering

8.1. fertility Market, by Offering, 2017-2030
8.1.1. Assisted Reproductive Technology
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.1.2. IVF
8.1.1.3. Market Revenue and Forecast (2017-2030)
8.1.1.4. Artificial Insemination
8.1.1.5. Market Revenue and Forecast (2017-2030)
8.1.1.6. Surrogacy
8.1.1.7. Market Revenue and Forecast (2017-2030)
8.1.1.8. Others
8.1.1.9. Market Revenue and Forecast (2017-2030)
8.1.2. Fertility Drugs
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.2.2. Gonadotropin
8.1.2.3. Market Revenue and Forecast (2017-2030)
8.1.2.4. Anti-estrogen
8.1.2.5. Market Revenue and Forecast (2017-2030)
8.1.2.6. Others
8.1.2.7. Market Revenue and Forecast (2017-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Fertility Market, By End user

9.1. fertility Market, by Grade, 2017-2030
9.1.1. Fertility Clinics
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Clinical Research Institutes
9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Fertility Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue Forecast by Offering (2017-2030)
10.1.2. Market Revenue Forecast by End-user(2017-2030)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2017-2030)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2017-2030)
10.2. Europe
10.2.1. Market Revenue Forecast by Offering (2017-2030)
10.2.2. Market Revenue Forecast by End-user (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2017-2030)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2017-2030)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Offering (2017-2030)
10.3.2. Market Revenue Forecast by End-user (2017-2030)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2017-2030)
10.4. LATAM
10.4.1. Market Revenue Forecast by Offering (2017-2030)
10.4.2. Market Revenue Forecast by End-user (2017-2030)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2017-2030)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2017-2030)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Offering (2017-2030)
10.5.2. Market Revenue Forecast by End-user (2017-2030)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2017-2030)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2017-2030)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2017-2030)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2017-2030)

Chapter 11. Company Profiles

11.1. Boston IVF Fertility Clinic
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin (2017-2020)
11.1.4. Recent Developments and Strategies
11.2. INVO Bioscience
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin (2017-2020)
11.2.4. Recent Developments and Strategies
11.3. San Diego Fertility Center
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin (2017-2020)
11.3.4. Recent Developments and Strategies
11.4. Celmatix
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin (2017-2020)
11.4.4. Recent Developments and Strategies
11.5. FUJIFILM IRVINE SCIENTIFIC
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin (2017-2020)
11.5.4. Recent Developments and Strategies
11.6. Carolinas Fertility Institute
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin (2017-2020)
11.6.4. Recent Developments and Strategies
11.7. Progyny Inc.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin (2017-2020)
11.7.4. Recent Developments and Strategies
11.8. Cook Medical
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin (2017-2020)
11.8.4. Recent Developments and Strategies
11.9. LifeGlobal Group (Cooper Surgical)
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin (2017-2020)
11.9.4. Recent Developments and Strategies